GlassScriptPhysician profile
Brandy J Khodr
NPI 1144730201
$10,465.85
in general payments reported to CMS, 2019-2025
43 companies · $2,082 in 2025
The $2,082 reported for 2025 was more than what 94% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,027 · 2022: $1,445 · 2023: $2,047 · 2024: $3,864 · 2025: $2,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,477 · Travel and Lodging: $1,489 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,477.32 |
| Travel and Lodging | $1,489.09 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,342.59 | 2023-2024 | Axonics |
| Medtronic, INC. | $1,054.66 | 2024 | Interstim |
| Myriad Genetic Laboratories, INC. | $883.36 | 2021-2025 | Prolaris, Bracanalysis Cdx |
| Sumitomo Pharma America, INC. | $773.33 | 2023-2025 | Gemtesa, Orgovyx, Myfembree |
| Antares Pharma, INC. | $727.96 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $579.85 | 2021-2025 | |
| Astellas Pharma US INC | $566.54 | 2021-2025 | Xtandi |
| Pfizer INC. | $484.67 | 2022-2025 | |
| Janssen Biotech, INC. | $339.56 | 2023-2025 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $328.33 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Endo Pharmaceuticals INC. | $309.25 | 2021-2023 | Aveed, Xiaflex |
| Progenics Pharmaceuticals, INC. | $236.07 | 2022-2025 | Pylarify |
| 180 Medical, INC. | $234.51 | 2023-2025 | Gentlecath Glide, Gentlecath |
| Tolmar, INC. | $199.95 | 2023-2025 | Eligard, Jatenzo |
| Abbott Laboratories | $194.98 | 2021-2022 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $193.13 | 2025 | Provenge |
| Endo USA, INC. | $184.60 | 2024-2025 | Aveed, Xiaflex |
| Abc Home Medical Supply, INC. | $169.72 | 2022-2025 | |
| Abbvie INC. | $136.51 | 2022-2025 | |
| Biotissue Holdings INC. | $122.78 | 2024-2025 | |
| Urovant Sciences INC | $120.85 | 2022 | |
| Ferring Pharmaceuticals INC. | $117.78 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $109.70 | 2023-2025 | Jelmyto |
| Convatec INC. | $104.38 | 2022-2023 | |
| Acerus Pharmaceuticals Corporation | $103.73 | 2021-2022 | |
| Halozyme INC | $100.95 | 2023 | |
| Tempus Ai, INC | $100.00 | 2024 | |
| Verity Pharmaceuticals INC. | $93.61 | 2025 | Trelstar, Tlando |
| Procept Biorobotics Corporation | $82.71 | 2022-2025 | |
| Boston Scientific Corporation | $68.52 | 2024 | Ams 700, Spaceoar Vue System - 10ml |
| Novartis Pharmaceuticals Corporation | $51.31 | 2025 | |
| Immunitybio, INC. | $46.66 | 2025 | |
| Hollister Incorporated | $44.37 | 2023 | Vapro Pocket |
| Telix Pharmaceuticals | $40.68 | 2023-2024 | Illuccix |
| Azurity Pharmaceuticals, INC. | $36.29 | 2025 | Azmiro |
| Teleflex LLC | $33.85 | 2023 | Urolift |
| Ambu INC. | $29.16 | 2025 | |
| Dexcom, INC. | $28.32 | 2021 | |
| Baxter Healthcare | $25.39 | 2023 | Tisseel |
| Avanos Medical | $19.00 | 2023 | On-Q* Pump and Accessories |
| Alnylam Pharmaceuticals INC. | $16.04 | 2023 | Oxlumo |
| Clarus Therapeutics INC. | $15.94 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Khodr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.